Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

You must log in to access content on this page. Or click here to request access.
There is a brighter future through fluorescent technology.
MediBeacon Ocular Angiography Program

MediBeacon is poised to begin first in-human clinical studies to establish the feasibility of using Lumitrace® to visualize the vasculature of the eye in ocular angiography systems.*

A Small Business Innovation Research (SBIR) grant supported by the National Eye Institute (NEI) of the National Institutes of Health (NIH) under Award Number R43EY027207 was awarded to MediBeacon in support of research into the use of a MediBeacon fluorescent tracer agent to visualize vasculature in the eye.

Use of fluorescent agent-based ocular angiography can show retinal circulation details that are not seen in imaging technologies that do not employ a tracer agent.
– Retina Today, J. Chhablani et al., Fluorescein Angiography and Optical Coherence Tomography correlation in various retinal diseases, January/February 2014
Diagnosing and monitoring vasculature leakage in the eye is a key factor in diagnosing and monitoring various disease states including the following.
Diabetic Retinopathy
Diabetic Retinopathy is the most common cause of vision loss among diabetics and a leading cause of blindness in working-age adults.
- National Eye Institute,
Macular Degeneration
Macular Degeneration is the leading cause of vision loss, affecting more than 10 million Americans.
- American Macular Degeneration Foundation,
Retinal Vasculitis
Retinal Vasculitis is the inflammation of retina vessels. Detection and characterization may help in diagnosis and management of certain disorders including systemic autoimmune disorders, some infectious diseases, and certain ocular disorders.
- La Revue de Médecine Interne, P. Gascon et al., Retinal vasculitis and systemic diseases, September 2018